Elequin Capital’s Xerox XRX Stock Holding History

Elequin Capital’s Portfolio XRX Stock Details XRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$133	Sell	199 -90	-31%	-$178	﹤0.01%	606
2025 Q4	$685	Buy	+289	New	+$855	﹤0.01%	384
2025 Q1	–	Sell	-406	Closed	-$3.42K	–	672
2024 Q4	$3.42K	Buy	406 +2	+0.5%	+$18	﹤0.01%	432
2024 Q3	$4.19K	Buy	+404	New	+$4.32K	﹤0.01%	299

Other funds holding XRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Elequin Capital's XRX Position: Q1 2026 in Review

Elequin Capital reduced its Xerox (XRX) stake by 31% in Q1 2026, selling an estimated $178 and leaving 199 shares worth $133. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Elequin Capital first reported a position in XRX in Q3 2024 and has held it in 4 quarters since. The position peaked at $4.19K in Q3 2024. 219 funds tracked by Wall St. Rank hold XRX as of Q1 2026.

Elequin Capital held 199 shares of Xerox worth $133 as of Q1 2026.
Elequin Capital sold 90 Xerox shares in Q1 2026, an estimated $178.
Xerox made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #606 holding.
Elequin Capital first reported a position in Xerox in Q3 2024 and has held it in 4 quarters since.
Elequin Capital's Xerox position peaked at $4.19K in Q3 2024.
219 funds tracked by Wall St. Rank held Xerox as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.